In summary, the three-marker panel with ITIH5, DKK3, and RASSF1A exhibits significantly increased levels of methylation in serum cfDNA from breast cancer patients compared with both age-matched healthy women and women with a benign breast disease. Here, RASSF1 is linked to breast fibrocystic disease.